Clinical Trials Directory

Trials / Completed

CompletedNCT04025736

Arthroscopic Shoulder Surgery With Administration of Intravenous Tranexamic Acid

Intravenous Administration of Tranexamic Acid Significantly Improved Clarity of Visual Field in Arthroscopic Shoulder Surgery. A Prospective, Double-blind and Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
National Cheng-Kung University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Purpose: The study aimed to determine whether intravenous administration of tanexamic acid (TXA) before shoulder arthroscopic rotator cuff repair surgery can improve arthroscopy visual clarity. Methods: This is a prospective, double-blinded, randomized and placebo-controlled study. From May 2016 to April 2018, patients requiring arthroscopic rotator cuff repair were enrolled and randomly assigned to either the TXA group that received 1000mg tranexamic acid intravenously 10 minutes before surgery or the placebo group that received the same volume of plain saline. Patients with pre-existing liver/renal disease, coagulopathy, or concurrent use of anti-coagulation medications were excluded. The visual clarity was rated by a numeric rating scale from grade 1(poor) to grade 3(clear) every 15 minutes throughout the surgery. Secondary outcomes included estimated perioperative blood loss, operative time, degree of shoulder swelling, postoperative subjective pain score, inpatient duration and associated comorbidities were recorded. Both parametric and nonparametric methods were used for statistical analysis.

Conditions

Interventions

TypeNameDescription
DRUGTranexamic Acid 100Mg/Ml Inj Vil 10MlTranexamic acid (TXA) is a synthetic analog of the amino acid lysine which acts by competitively blocking the plasminogen lysine-binding site and inhibiting fibrinolysis. Several studies showed that TXA could reduce both blood loss and the amount of blood transfusion after shoulder arthroplasty surgeries.
DRUG0.9% Sodium Chloride InjectionNormal saline is a mixture of sodium chloride in water and has a number of uses in medicine. We use the same volume of normal saline as placebo.

Timeline

Start date
2017-06-07
Primary completion
2018-02-28
Completion
2018-02-28
First posted
2019-07-19
Last updated
2019-07-19

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04025736. Inclusion in this directory is not an endorsement.